Findings

What do systematic reviews say?

67 questions · 69 findings · 24 reviews · Airways

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2 · 2.9%GRADE not reported 3 · 4.3%Very low 11 · 15.9%Low 26 · 37.7%Moderate 19 · 27.5%High 8 · 11.6%

Anti‐IL13 or anti‐IL4 agents vs placebo

Change from baseline in ACQ score Scale: 0 to 6 (higher is worse) · people with asthma

1 finding from 1 review

Anti‐interleukin‐13 and anti‐interleukin‐4 agents versus placebo, anti‐interleukin‐5 or anti‐immunoglobulin‐E agents,… 2021 · Cochrane Headline outcomes only
no estimate extracted
14 studies · 6251 participants
Moderate

Breathing exercises vs inactive control

Change in AQLQ · adults with asthma

1 finding from 1 review

Breathing exercises for adults with asthma 2020 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 974 participants
Moderate

Group 1 Pulmonary arterial hypertension ‐ PDE5i vs placebo, on combination therapy

Physical functioning component of health‐related quality of life, measured using various scales · pulmonary arterial hypertension

1 finding from 1 review

Phosphodiesterase 5 inhibitors for pulmonary hypertension 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 267 participants
Moderate

Group 1 Pulmonary arterial hypertension ‐ PDE5i vs ERA

Quality of life Kansas City Cardiomyopathy Quality‐of‐Life questionnaire (higher scores indicate better quality of life) · pulmonary arterial hypertension

1 finding from 1 review

Phosphodiesterase 5 inhibitors for pulmonary hypertension 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 25 participants
Low

Group 1 Pulmonary arterial hypertension ‐ PDE5i vs placebo

QoL · pulmonary arterial hypertension

1 finding from 1 review

Phosphodiesterase 5 inhibitors for pulmonary hypertension 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 163 participants
GRADE not reported

Selexipag vs placebo

mPAP (the higher the mPAP, the worse the pulmonary hypertension) · pulmonary arterial hypertension

1 finding from 1 review

Prostacyclin for pulmonary arterial hypertension 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 43 participants
Moderate

Selexipag vs placebo

PVR · pulmonary arterial hypertension

1 finding from 1 review

Prostacyclin for pulmonary arterial hypertension 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 43 participants
Moderate

Prostacyclin vs control

mPAP (the higher the mPAP, the worse the pulmonary hypertension) · pulmonary arterial hypertension

1 finding from 1 review

Prostacyclin for pulmonary arterial hypertension 2019 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 1132 participants
Low

Prostacyclin vs control

PVR · pulmonary arterial hypertension

1 finding from 1 review

Prostacyclin for pulmonary arterial hypertension 2019 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 658 participants
Moderate

Summary of findings for AMBMT + PR vs PR

Dyspnoea ‐ CRQ dyspnoea Scale 1 to 7. Higher is better and 0.5 units is a clinically important difference · patients with chronic obstructive pulmonary disease

1 finding from 1 review

Active mind‐body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with… 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 80 participants
Very low

Summary of findings for AMBMT vs PR

Change in dyspnoea score · patients with chronic obstructive pulmonary disease

1 finding from 1 review

Active mind‐body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with… 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 11 participants
Very low

Summary of findings for AMBMT + PR vs PR

General health‐related quality of life · patients with chronic obstructive pulmonary disease

1 finding from 1 review

Active mind‐body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with… 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 80 participants
Very low

Summary of findings for AMBMT + PR vs PR

Health‐related quality of life (mental) · patients with chronic obstructive pulmonary disease

1 finding from 1 review

Active mind‐body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with… 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 80 participants
Very low

Intervention not reported

Staff preparedness ‐ asthma knowledge NAKQ 0 to 31 scale; higher is better. 1 to 8 months · school staff

1 finding from 1 review

Asthma education for school staff 2017 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 640 participants
Low

Intervention not reported

Health‐related quality of life (generic) SF‐36 (Physical Component Summary (PCS) score) Scale from 0‐100 Higher value post intervention is favourable, indicating improvement in health‐related quality of life · people with stable COPD

1 finding from 1 review

Singing for adults with chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 52 participants
Low

Intervention not reported

Health‐related quality of life (generic) SF‐36 (Mental Component Sumary (MCS) score) Scale from 0‐100 Higher value post intervention is favourable, indicating improvement in health‐related quality of life · people with stable COPD

1 finding from 1 review

Singing for adults with chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 52 participants
Low

Intervention not reported

Dyspnoea Basal Dyspnea Index (BDI) (score) Scale from 0‐12 Higher value post intervention is favourable, indicating improvement in dyspnoea · people with stable COPD

1 finding from 1 review

Singing for adults with chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 30 participants
Very low

Intervention not reported

Health‐related quality of life ‐ all trials Higher scores indicate improved health‐related quality of life · patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy

1 finding from 1 review

Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen… 2016 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 267 participants
Low

Intervention not reported

Lung function % predicted trough FEV1 higher = better 7.6‐month · people with asthma

1 finding from 1 review

Home telemonitoring and remote feedback between clinic visits for asthma 2016 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 149 participants
Moderate

Intervention not reported

Asthma‐related quality of life (AQLQ) Scale 1 to 7; higher is better 8 months · adults or children with asthma

1 finding from 1 review

Remote versus face‐to‐face check‐ups for asthma 2016 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 544 participants
Moderate